Roux, Ö. L., Everitt, J. I., & Counter, C. M. p53 dosage can impede KrasG12D- and KrasQ61R-mediated tumorigenesis. Public Library of Science (PLoS).
Chicago Style (17th ed.) CitationRoux, Özgün Le, Jeffery I. Everitt, and Christopher M. Counter. P53 Dosage Can Impede KrasG12D- and KrasQ61R-mediated Tumorigenesis. Public Library of Science (PLoS).
MLA (9th ed.) CitationRoux, Özgün Le, et al. P53 Dosage Can Impede KrasG12D- and KrasQ61R-mediated Tumorigenesis. Public Library of Science (PLoS).
Warning: These citations may not always be 100% accurate.